Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study
Abstract Background To provide basic demographic information and clinicopathologic features of ophthalmic Rosai–Dorfman disease (RDD) with a literature review. Methods A multi-centre retrospective case series reviewing all patients with histopathologically confirmed ophthalmic RDD at three tertiary...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b68b8218af734c1f8f9d60defe58acfd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b68b8218af734c1f8f9d60defe58acfd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b68b8218af734c1f8f9d60defe58acfd2021-11-28T12:42:18ZOphthalmic Rosai–Dorfman disease: a multi-centre comprehensive study10.1186/s12886-021-02173-11471-2415https://doaj.org/article/b68b8218af734c1f8f9d60defe58acfd2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12886-021-02173-1https://doaj.org/toc/1471-2415Abstract Background To provide basic demographic information and clinicopathologic features of ophthalmic Rosai–Dorfman disease (RDD) with a literature review. Methods A multi-centre retrospective case series reviewing all patients with histopathologically confirmed ophthalmic RDD at three tertiary eye care centres between January 1993 and December 2018. Results Eleven eyes of eight patients with histopathologically confirmed ophthalmic RDD were included, with equal numbers of males and females. The median age was 40.25 years (range: 26.6–72.4). Two patients had familial RDD. The orbit was the most commonly involved site (90.9% eyes). One patient (one eye) presented with a scleral nodule, anterior uveitis and cystoid macular oedema. Visual acuity ranged from 20/25 to light perception. Six patients had an extra-nodal ophthalmic disease, and the remaining two had an associated submandibular lymphadenopathy (nodal RDD). Conclusions Ophthalmic RDD can be the only manifestation of this systemic disease, with the orbit being the most commonly involved site, exhibiting bone destruction, intracranial and/or sinus involvement and variable degree of visual loss. Ophthalmic familial RDD represent a severe form with a malignant course. Steroid monotherapy may be inadequate to control orbital RDD; thus, combined treatment is usually necessary. A comprehensive approach to assessment and management is recommended.Tariq A. AlzahemAntonio Augusto CruzAzza M. Y. MaktabiFernando ChahudHind AlkatanBMCarticleRosai–Dorfman diseaseOrbitFamilialHistopathologyLymphadenopathyOphthalmologyRE1-994ENBMC Ophthalmology, Vol 21, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Rosai–Dorfman disease Orbit Familial Histopathology Lymphadenopathy Ophthalmology RE1-994 |
spellingShingle |
Rosai–Dorfman disease Orbit Familial Histopathology Lymphadenopathy Ophthalmology RE1-994 Tariq A. Alzahem Antonio Augusto Cruz Azza M. Y. Maktabi Fernando Chahud Hind Alkatan Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study |
description |
Abstract Background To provide basic demographic information and clinicopathologic features of ophthalmic Rosai–Dorfman disease (RDD) with a literature review. Methods A multi-centre retrospective case series reviewing all patients with histopathologically confirmed ophthalmic RDD at three tertiary eye care centres between January 1993 and December 2018. Results Eleven eyes of eight patients with histopathologically confirmed ophthalmic RDD were included, with equal numbers of males and females. The median age was 40.25 years (range: 26.6–72.4). Two patients had familial RDD. The orbit was the most commonly involved site (90.9% eyes). One patient (one eye) presented with a scleral nodule, anterior uveitis and cystoid macular oedema. Visual acuity ranged from 20/25 to light perception. Six patients had an extra-nodal ophthalmic disease, and the remaining two had an associated submandibular lymphadenopathy (nodal RDD). Conclusions Ophthalmic RDD can be the only manifestation of this systemic disease, with the orbit being the most commonly involved site, exhibiting bone destruction, intracranial and/or sinus involvement and variable degree of visual loss. Ophthalmic familial RDD represent a severe form with a malignant course. Steroid monotherapy may be inadequate to control orbital RDD; thus, combined treatment is usually necessary. A comprehensive approach to assessment and management is recommended. |
format |
article |
author |
Tariq A. Alzahem Antonio Augusto Cruz Azza M. Y. Maktabi Fernando Chahud Hind Alkatan |
author_facet |
Tariq A. Alzahem Antonio Augusto Cruz Azza M. Y. Maktabi Fernando Chahud Hind Alkatan |
author_sort |
Tariq A. Alzahem |
title |
Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study |
title_short |
Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study |
title_full |
Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study |
title_fullStr |
Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study |
title_full_unstemmed |
Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study |
title_sort |
ophthalmic rosai–dorfman disease: a multi-centre comprehensive study |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/b68b8218af734c1f8f9d60defe58acfd |
work_keys_str_mv |
AT tariqaalzahem ophthalmicrosaidorfmandiseaseamulticentrecomprehensivestudy AT antonioaugustocruz ophthalmicrosaidorfmandiseaseamulticentrecomprehensivestudy AT azzamymaktabi ophthalmicrosaidorfmandiseaseamulticentrecomprehensivestudy AT fernandochahud ophthalmicrosaidorfmandiseaseamulticentrecomprehensivestudy AT hindalkatan ophthalmicrosaidorfmandiseaseamulticentrecomprehensivestudy |
_version_ |
1718407853668040704 |